Eikon.
Open platform with access to real time market data, news, fundamental data, analytics, trading and messaging tools
Eikon announces seven cancer-drug abstracts for ESMO
Eikon Therapeutics announced that seven abstracts covering four oncology drug candidates will be presented at the 2026 ESMO Congress in Madrid. The disclosures will include clinical-trial updates for treatments being studied in lung, prostate and other advanced cancers, as well as early safety and pharmacokinetic data.
Health · 6 sources · 2hRead itThe journal
Open the journal →The conversation starts in the journal — be the first to post.
About Eikon
Eikon is a set of software products set to be fully replaced by LSEG Workspace in 2025. It is designed for financial professionals to monitor and analyse financial information. It provides access to real time market data, news, fundamental data, analytics, trading and messaging tools. It provides data on asset classes including foreign exchange, money markets, fixed income, equities, commodities, funds, and real estate.
Everything about Eikon →- Website
- https://www.refinitiv.com/en/products/eikon-trading-software